Summit Global Investments’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
Summit Global Investments's ACLS Position: Q3 2026 in Review
Summit Global Investments reduced its Axcelis (ACLS) stake by 35% in Q3 2026, selling an estimated $332K and leaving 4,737 shares worth $621K. The position accounts for 0.03% of the portfolio, ranked #322.
Summit Global Investments first reported a position in ACLS in Q1 2023 and has held it in 11 quarters since. The position peaked at $1.39M in Q2 2026. 132 funds tracked by Wall St. Rank hold ACLS as of Q3 2026.
- Summit Global Investments held 4,737 shares of Axcelis worth $621K as of Q3 2026.
- Summit Global Investments sold 2,597 Axcelis shares in Q3 2026, an estimated $332K.
- Axcelis made up 0.03% of Summit Global Investments's portfolio in Q3 2026, its #322 holding.
- Summit Global Investments first reported a position in Axcelis in Q1 2023 and has held it in 11 quarters since.
- Summit Global Investments's Axcelis position peaked at $1.39M in Q2 2026.
- 132 funds tracked by Wall St. Rank held Axcelis as of Q3 2026.
Based on Summit Global Investments's 13F filing for Q3 2026, filed 28 Oct 2026.